Latest revision as of 10:19, 10 March 2015

Meeting details

Wednesday, 11 March 2015, 14:00 CET

WebEx details:

Meeting number: 959 390 393

CP mtp-pre-1: link PRE --> MTP & type of referenced content
- Draft here
- Goal: distinguish between reference to PRE and reference to MTP (same content)

CP mtp-pre-2: Reference to original CDA document (when in PML)
- Draft here
- Goal: when included in a PML, preserve the fact that several PREs or MTPs are coming from the same CDA document
- Useful also for DIS and PADV?

@@ Line 15: / Line 15: @@
 === Review of MTP Profile document ===
-* Section ...
+* [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/MedicationTreatmentPlan,%20MTP/IHE_Suppl_MTP_Rev04_2015-02-27.docx Draft here]
-** Concepts
-** Use cases
-* Section ...
-* IDs
-** ....
-== Profile ==
+* Glossary & definitions (pages 8, 10, 25)
+* Reported medications (page 16)
+* Next steps
+<p>&nbsp;</p>
+=== Review of CPs ===
+* CP mtp-pre-1: link PRE --> MTP & type of referenced content
+** [ftp://ftp.ihe.net/Pharmacy/TF_Maintenance-2015/CPs/Drafts/CP-PHARM-mtp-pre-1.doc Draft here]
+** Goal: distinguish between reference to PRE and reference to MTP (same content)
+<p>&nbsp;</p>
+* CP mtp-pre-2: Reference to original CDA document (when in PML)
+** [ftp://ftp.ihe.net/Pharmacy/TF_Maintenance-2015/CPs/Drafts/CP-PHARM-mtp-pre-2.doc Draft here]
+** Goal: when included in a PML, preserve the fact that several PREs or MTPs are coming from the same CDA document
+** Useful also for DIS and PADV?
+<p>&nbsp;</p>
+=== Review of CMPD Profile document ===
+* [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/MedicationTreatmentPlan,%20MTP/IHE_Pharmacy_Suppl_CMPD_Rev1.5_TI_2015-03-10.docx Draft here]